Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Mol. Neurosci.

Sec. Molecular Signalling and Pathways

Volume 18 - 2025 | doi: 10.3389/fnmol.2025.1596649

Nfkbia-Driven Neuroinflammatory Pathways Mediate Depression Following Spinal Cord Injury

Provisionally accepted
Aichun  YangAichun Yang1Guo-Yuan  HeGuo-Yuan He2,3,4Yanling  SongYanling Song1Yujun  WenYujun Wen3Hechun  XiaHechun Xia4,5*Shenhong  GuShenhong Gu1*
  • 1First Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, China
  • 2Ningxia Medical University, Yinchuan, Ningxia, China
  • 3Ningxia Key Laboratory of Cerebrocranial Disease, Ningxia Medical University, Yinchuan, Ningxia Hui Region, China
  • 4Department of Key Laboratory of Ningxia Stem Cell and Regenerative Medicine, General Hospital of Ningxia Medical University, Yinchuan, Henan Province, China
  • 5Department of Neurosurgery, General Hospital of Ningxia Medical University, Yichuan, China

The final, formatted version of the article will be published soon.

Introduction: Spinal cord injury (SCI) frequently leads to severe motor impairments and psychological issues, particularly depression, which negatively affects overall quality of life. This study seeks to clarify the relationship between SCI and depression by employing a comprehensive approach that includes behavioral assessments, transcriptomic profiling, and molecular analyses.We established a weight-drop model of SCI and randomly assigned mice to Sham and SCI groups. Behavioral assessments included the Open Field Test (OP), Sucrose Preference Test (SP), and Tail Suspension Test (TS). We conducted transcriptomic analyses using datasets related to SCI and major depressive disorder (MDD) sourced from the GEO database. The hub gene, Nfkbia, was identified with Cytoscape software and validated through RT-PCR. Western blotting was utilized to measure the protein levels of IκB-α (encoded by Nfkbia) and phosphorylated p65 (p-p65).Additionally, we examined hippocampal histopathology and measured pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α).Results: Following SCI, mice displayed abnormal behaviors in the OP, SP, and TS, suggesting the development of depression-like symptoms. In light of these observations, we analyzed publicly available transcriptomic datasets related to SCI and depression, identifying 16 common differentially expressed genes. Functional enrichment analysis showed that these genes were primarily associated with biological processes linked to inflammatory responses. We constructed a protein-protein interaction network that highlighted four potential key genes (Nfkbia, Fkbp5, Sgk1, and Cdkn1a). Subsequent molecular biology experiments confirmed that Nfkbia was downregulated after SCI, resulting in an increase in inflammatory factor production and the emergence of depression-like behaviors in mice.Discussion: Our results suggest that neuroinflammation plays a crucial role in the onset of depression after SCI. This is supported by the activation of the IκB/p65 signaling pathway and the dysregulation of inflammatory cytokines. These findings align with clinical observations of mood disorders in patients with SCI and reflect known patterns of inflammatory cytokine dysregulation.This study underscores the significance of anti-inflammatory treatments and comprehensive neuropsychiatric management strategies in the rehabilitation of SCI patients.

Keywords: spinal cord injury, Depression, Neuroinflammation, NFKBIA, bioinformatics

Received: 04 Apr 2025; Accepted: 26 Aug 2025.

Copyright: © 2025 Yang, He, Song, Wen, Xia and Gu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Hechun Xia, Department of Key Laboratory of Ningxia Stem Cell and Regenerative Medicine, General Hospital of Ningxia Medical University, Yinchuan, Henan Province, China
Shenhong Gu, First Affiliated Hospital of Hainan Medical University, Haikou, 570102, Hainan Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.